0001104659-18-016854.txt : 20180312 0001104659-18-016854.hdr.sgml : 20180312 20180312203224 ACCESSION NUMBER: 0001104659-18-016854 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180228 FILED AS OF DATE: 20180312 DATE AS OF CHANGE: 20180312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDENBERG DAVID M CENTRAL INDEX KEY: 0001029578 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12104 FILM NUMBER: 18684993 MAIL ADDRESS: STREET 1: UBS GLOBAL ASSET MANAGEMENT (US) INC. STREET 2: 51 WEST 52ND STREET CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOMEDICS INC CENTRAL INDEX KEY: 0000722830 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 611009366 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 300 AMERICAN RD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 BUSINESS PHONE: 9736058200 MAIL ADDRESS: STREET 1: 300 AMERICAN ROAD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 4 1 a4.xml 4 X0306 4 2018-02-28 0 0000722830 IMMUNOMEDICS INC IMMU 0001029578 GOLDENBERG DAVID M C/O IMMUNOMEDICS, INC 300 THE AMERICAN ROAD MORRIS PLAINS NJ 07950 1 0 0 0 Common Stock 2018-03-07 4 S 0 20000 17.50 D 1774285 D Common Stock 2018-02-28 4 S 0 17729 17.09 D 5693252 I See Footnote Common Stock 2018-03-05 4 S 0 20000 17.30 D 5673252 I See Footnote Common Stock 2018-03-05 4 S 0 20000 17.17 D 5653252 I See Footnote Common Stock 2018-03-07 4 S 0 20000 17.60 D 5633252 I See Footnote Common Stock 2018-03-07 4 S 0 20000 17.75 D 5613252 I See Footnote Such shares were held by the reporting person's spouse, Ms. Cynthia L. Goldenberg, also known as Cynthia L. Sullivan. Includes a total of 635,935 shares held as joint tenants by the reporting person and his spouse, Ms. Cynthia L. Goldenberg, also known as Cynthia L. Sullivan, a director of the Company. Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interests therein. /s/ Dr. David M. Goldenberg 2018-03-12